In the human population, the chemo-prevention and protective nature of phytoestrogens in prostate cancer is hypothesized to rely on the high binding affinity and activating potential of these estrogenic compounds for ERβ (Kuiper et al. 1998; Leung et al. 2006). This evidence concerns the gene ESR2 and prostate carcinoma.